ACHN - アキリオン・ファ―マシュ―ティカルズ (Achillion Pharmaceuticals Inc.)

ACHNのニュース

   The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics  2020/01/28 12:12:23 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN )(announced early termination of waiting period for its proposed acquisition by Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN )) Cidara Therapeutics Inc (NASDAQ: CDTX ) Cleveland BioLabs, Inc. (NASDAQ: CBLI )(saw a coronavirus-induced rally ) Denali Therapeutics Inc (NASDAQ: DNLI ) Dr.Reddy's Laboratories Ltd (NYSE: RDY )(reacted to its Q3 results) Inovio Pharmaceuticals Inc (NASDAQ: INO )(announced Nevro Corp (NYSE: NVRO ) Oyster Point Pharma Inc (NASDAQ: OYST ) Quest Diagnostics Inc (NYSE: DGX ) Rapt Therapeutics Inc (NASDAQ: RAPT ) SI-Bone Inc (NASDAQ: SIBN ) Vaccinex Inc (NASDAQ: VCNX ) Vir Biotechnology Inc (NASDAQ: VIR ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Jan. 27) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) Avanos Medical Inc (NYSE: AVNS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Correvio Pharma Corp (NASDAQ: CORV ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Heat Biologics Inc (NASDAQ: HTBX ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Kura Oncology Inc (NASDAQ: KURA ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) MediciNova, Inc.
   Achillion Reports Positive Data from Phase 2 Study of Danicopan  2019/12/09 16:59:03 Investing News Network
The company announced results at the 61st American Society of Hematology (ASH) Annual Meeting in Orlando, Florida. The post Achillion Reports Positive Data from Phase 2 Study of Danicopan appeared first on Investing News Network .
   Why Is Achillion (ACHN) Down 2.8% Since Last Earnings Report?  2019/12/07 16:31:15 Zacks Investment Research
Achillion (ACHN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Rigrodsky & Long, P.A. Files Class Action Suit Against Achillion Pharmaceuticals, Inc.  2019/11/30 04:30:00 GlobeNewswire
WILMINGTON, Del., Nov. 29, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Rigrodsky & Long, P.A. announces that it has filed a class action…
   Brokerages Set Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) PT at $4.96  2019/11/16 01:41:59 Modern Readers
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has earned an average recommendation of “Hold” from the eight analysts that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month target price among […]
   Achillion Reports Positive Data from Phase 2 Study of Danicopan  2019/12/09 16:59:03 Investing News Network
The company announced results at the 61st American Society of Hematology (ASH) Annual Meeting in Orlando, Florida. The post Achillion Reports Positive Data from Phase 2 Study of Danicopan appeared first on Investing News Network .
   Why Is Achillion (ACHN) Down 2.8% Since Last Earnings Report?  2019/12/07 16:31:15 Zacks Investment Research
Achillion (ACHN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Rigrodsky & Long, P.A. Files Class Action Suit Against Achillion Pharmaceuticals, Inc.  2019/11/30 04:30:00 GlobeNewswire
WILMINGTON, Del., Nov. 29, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Rigrodsky & Long, P.A. announces that it has filed a class action…
   Brokerages Set Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) PT at $4.96  2019/11/16 01:41:59 Modern Readers
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has earned an average recommendation of “Hold” from the eight analysts that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month target price among […]
   Here is What Hedge Funds Think About Achillion Pharmaceuticals, Inc. (ACHN)  2019/11/06 19:36:44 Yahoo Finance
Billionaire hedge fund managers such as David Abrams, Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses
   Achillion Pharmaceuticals EPS in-line  2019-05-09
Achillion Pharmaceuticals (NASDAQ: ACHN ): Q1 GAAP EPS of -$0.14 in-line. More news on: Achillion Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more …

calendar